Perspective Therapeutics Inc (AMEX: CATX) on Monday, plunged -5.21% from the previous trading day, before settling in for the closing price of $2.88. Within the past 52 weeks, CATX’s price has moved between $1.60 and $5.39.
During the last 5-year period, the sales drop of Healthcare Sector giant was -9.86%. The company achieved an average annual earnings per share of 0.32%. With a float of $61.65 million, this company’s outstanding shares have now reached $74.34 million.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Perspective Therapeutics Inc is 17.07%, while institutional ownership is 63.28%. The most recent insider transaction that took place on Nov 13 ’25, was worth 22,295. In this transaction Chief Accounting Officer of this company bought 11,000 shares at a rate of $2.03, taking the stock ownership to the 59,800 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director bought 9,498 for $2.10, making the entire transaction worth $19,946. This insider now owns 9,864 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.24 earnings per share (EPS) for the period topping the consensus outlook (set at -0.25) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.62% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Perspective Therapeutics Inc (CATX) is currently performing well based on its current performance indicators. A quick ratio of 8.66 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 189.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Looking closely at Perspective Therapeutics Inc (AMEX: CATX), its last 5-days average volume was 0.92 million, which is a drop from its year-to-date volume of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 79.26%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 22.57%, which indicates a significant decrease from 66.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was lower than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.55, while its 200-day Moving Average is $3.02. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $2.82. Second resistance stands at $2.90. The third major resistance level sits at $2.96. If the price goes on to break the first support level at $2.67, it is likely to go to the next support level at $2.62. Now, if the price goes above the second support level, the third support stands at $2.53.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
Market capitalization of the company is 202.94 million based on 74,338K outstanding shares. Right now, sales total 1,450 K and income totals -79,280 K. The company made 210 K in profit during its latest quarter, and -25,970 K in sales during its previous quarter.
